Teaching old receptors new tricks: biasing seven-transmembrane receptors

被引:659
作者
Rajagopal, Sudarshan [1 ]
Rajagopal, Keshava [2 ]
Lefkowitz, Robert J. [1 ,3 ,4 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA
基金
美国国家卫生研究院;
关键词
PROTEIN-COUPLED RECEPTOR; BETA-ADRENERGIC-RECEPTOR; LIGHT-DEPENDENT PHOSPHORYLATION; GROWTH-FACTOR RECEPTOR; TERNARY COMPLEX MODEL; ADENYLATE-CYCLASE; DRUG DISCOVERY; BETA(2)-ADRENERGIC RECEPTOR; CONFORMATIONAL-CHANGES; ERK1/2; ACTIVATION;
D O I
10.1038/nrd3024
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Seven-transmembrane receptors (7TMRs; also known as G protein-coupled receptors) are the largest class of receptors in the human genome and are common targets for therapeutics. Originally identified as mediators of 7TMR desensitization, beta-arrestins (arrestin 2 and arrestin 3) are now recognized as true adaptor proteins that transduce signals to multiple effector pathways. Signalling that is mediated by beta-arrestins has distinct biochemical and functional consequences from those mediated by G proteins, and several biased ligands and receptors have been identified that preferentially signal through either G protein- or beta-arrestin-mediated pathways. These ligands are not only useful tools for investigating the biochemistry of 7TMR signalling, they also have the potential to be developed into new classes of therapeutics.
引用
收藏
页码:373 / 386
页数:14
相关论文
共 119 条
[41]   A β-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis [J].
Ge, L ;
Ly, Y ;
Hollenberg, M ;
DeFea, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (36) :34418-34426
[42]   Structure and function of the third intracellular loop of the 5-hydroxytryptamine2A receptor:: The third intracellular loop is α-helical and binds purified arrestins [J].
Gelber, EI ;
Kroeze, WK ;
Willins, DL ;
Gray, JA ;
Sinar, CA ;
Hyde, EG ;
Gurevich, V ;
Benovic, J ;
Roth, BL .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (05) :2206-2214
[43]   Distinct β-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation [J].
Gesty-Palmer, D ;
Chen, MY ;
Reiter, E ;
Ahn, S ;
Nelson, CD ;
Wang, ST ;
Eckhardt, AE ;
Cowan, CL ;
Spurney, RF ;
Luttrell, LM ;
Lefkowitz, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (16) :10856-10864
[44]   A β-Arrestin-Biased Agonist of the Parathyroid Hormone Receptor (PTH1R) Promotes Bone Formation Independent of G Protein Activation [J].
Gesty-Palmer, Diane ;
Flannery, Pat ;
Yuan, Ling ;
Corsino, Leonor ;
Spurney, Robert ;
Lefkowitz, Robert J. ;
Luttrell, Louis M. .
SCIENCE TRANSLATIONAL MEDICINE, 2009, 1 (01)
[45]   α-Thrombin induces rapid and sustained Akt phosphorylation by β-arrestin1-dependent and -independent mechanisms, and only the sustained Akt phosphorylation is essential for G1 phase progression [J].
Goel, R ;
Phillips-Mason, PJ ;
Raben, DM ;
Baldassare, JJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (21) :18640-18648
[46]   beta-arrestin acts as a clathrin adaptor in endocytosis of the beta(2)-adrenergic receptor [J].
Goodman, OB ;
Krupnick, JG ;
Santini, F ;
Gurevich, VV ;
Penn, RB ;
Gagnon, AW ;
Keen, JH ;
Benovic, JL .
NATURE, 1996, 383 (6599) :447-450
[47]   An opioid agonist that does not induce μ-opioid receptor -: Arrestin interactions or receptor internalization [J].
Groer, C. E. ;
Tidgewell, K. ;
Moyer, R. A. ;
Harding, W. W. ;
Rothman, R. B. ;
Prisinzano, T. E. ;
Bohn, L. M. .
MOLECULAR PHARMACOLOGY, 2007, 71 (02) :549-557
[48]   Agonist-receptor-arrestin, an alternative ternary complex with high agonist affinity [J].
Gurevich, VV ;
PalsRylaarsdam, R ;
Benovic, JL ;
Hosey, MM ;
Onorato, JJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (46) :28849-28852
[49]   DISCRETE ACTIVATION OF TRANSDUCTION PATHWAYS ASSOCIATED WITH ACETYLCHOLINE-M1 RECEPTOR BY SEVERAL MUSCARINIC LIGANDS [J].
GURWITZ, D ;
HARING, R ;
HELDMAN, E ;
FRASER, CM ;
MANOR, D ;
FISHER, A .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 267 (01) :21-31
[50]  
Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830